Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-083686
Filing Date
2013-11-12
Accepted
2013-11-12 16:57:14
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19815_110q.htm 10-Q 1264741
2 EX-31.1 a13-19815_1ex31d1.htm EX-31.1 11623
3 EX-31.2 a13-19815_1ex31d2.htm EX-31.2 11604
4 EX-32.1 a13-19815_1ex32d1.htm EX-32.1 6439
5 EX-32.2 a13-19815_1ex32d2.htm EX-32.2 6430
  Complete submission text file 0001104659-13-083686.txt   10943137

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abbv-20130930.xml EX-101.INS 1652514
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20130930.xsd EX-101.SCH 75955
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20130930_cal.xml EX-101.CAL 84376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20130930_def.xml EX-101.DEF 440865
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT abbv-20130930_lab.xml EX-101.LAB 1530995
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20130930_pre.xml EX-101.PRE 721276
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 131211083
SIC: 2834 Pharmaceutical Preparations